SCHEMBL7019209

SCHEMBL7019209

NCCOCCN1CCC(n2cc(-c3ccccc3)c3c(N)ncnc32)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 13/20 0.66
EGFR P00533 12/20 0.64
ABL1 P00519 10/20 0.64
ABL2 P42684 9/20 0.64
LCK P06239 8/20 0.62
RIPK2 O43353 1/20 0.61
HCK P08631 3/20 0.58
BTK Q06187 4/20 0.57
TEK Q02763 5/20 0.56
KDR P35968 3/20 0.56
FYN P06241 2/20 0.56
LYN P07948 2/20 0.56
CSK P41240 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
RGS12 O14924 1/20 0.56
NPC1 O15118 1/20 0.56
GMNN O75496 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7017312 0.91 SRC (0.65) SRCEGFRABL1ABL2LCK
SCHEMBL7015822 0.89 ABL1 (0.77) SRCEGFRABL1ABL2LCK
SCHEMBL7017930 0.89 SRC (0.68) SRCEGFRABL1ABL2LCK
SCHEMBL7019170 0.88 EGFR (0.79) SRCEGFRABL1ABL2LCK
SCHEMBL22845563 0.86 HCK (0.80) SRCEGFRABL1LCKHCK
SCHEMBL22845296 0.86 HCK (0.80) SRCEGFRABL1LCKHCK
SCHEMBL7020164 0.86 SRC (0.81) SRCEGFRABL1ABL2LCK
SCHEMBL22835091 0.86 HCK (0.79) SRCEGFRABL1LCKHCK
SCHEMBL22845273 0.86 HCK (0.79) SRCEGFRABL1LCKHCK
SCHEMBL22845272 0.86 HCK (0.79) SRCEGFRABL1LCKHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP claimed
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed